Jose Carmona Adc Therapeutics Sa (ADCT) insider trading activity

ADCT Quotes by TradingView

Jose Carmona is Chief Financial Officer of ADC Therapeutics SA. Currently has a direct ownership of 488,656 shares of ADCT, which is worth approximately $1.94 Million. The most recent transaction as insider was on Dec 06, 2025, when has been sold 53,236 shares (Common Shares) at a price of $3.29 per share, resulting in proceeds of $175,146. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 489K
9.82% 3M change
61.86% 12M change
Total Value Held $1.94 Million

Jose Carmona Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2025
SELL
Payment of exercise price or tax liability
$175,146 $3.29 p/Share
53,236 Reduced 9.82%
488,656 Common Shares
Feb 13 2025
BUY
Grant, award, or other acquisition
$386,400 $1.61 p/Share
240,000 Added 30.69%
541,892 Common Shares
Dec 06 2024
SELL
Payment of exercise price or tax liability
$150,578 $3.13 p/Share
48,108 Reduced 13.75%
301,892 Common Shares

Also insider at

RUBY
Rubius Therapeutics, Inc. Healthcare
Chief Financial Officer
JC

Jose Carmona

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on ADCT

Follow ADC Therapeutics SA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADCT shares.

Notify only if

Insider Trading

Get notified when an Adc Therapeutics Sa insider buys or sells ADCT shares.

Notify only if

News

Receive news related to ADC Therapeutics SA

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADCT